一项实用随机控制的探索性试验,研究眼动脱敏和再处理治疗精神障碍的有效性
Simon Marlow1, Richard Laugharne2, Jon Allard1
1Cornwall Partnership NHS Foundation Trust, Truro, UK.
Journal of psychiatric research
|December 6, 2023
概括
眼动脱敏和再处理 (EMDR) 疗法显著减少了精神病患者的创伤影响. 这些心理健康症状的改善在英国社区环境下治疗后持续了六个月.
科学领域:
- 精神病学是一个精神病学.
- 心理学 心理学 心理学
- 创伤研究 创伤研究
背景情况:
- 严重的精神疾病,特别是精神疾病,由于安全问题,经常被排除在眼动脱敏和再处理 (EMDR) 试验之外.
- 新出现的证据表明精神疾病的创伤性病因,表明EMDR的潜在治疗益处.
- 目前用于精神疾病的EMDR应用主要局限于专业的第三级护理机构.
研究的目的:
- 在成人社区心理健康服务中进行一项随机探索性试验,评估EMDR治疗对患有精神疾病和创伤史的人的治疗.
- 在这个人群中,与通常治疗 (TAU) 相比,评估EMDR的预期治疗和六个月的随访.
主要方法:
- 在英国农村县进行了一项随机对照试验,涉及患有精神疾病和创伤史的参与者.
- 参与者被随机分配,接受EMDR或通常治疗 (TAU).
- 结果措施包括事件影响量表 (IES),PTSD检查清单 (PCL-C),精神病障碍的积极和消极症状 (PANSS) 和MANSA生活质量量量表.
主要成果:
- 与TAU组 (n=12) 相比,EMDR组 (n=24) 在10周和6个月 (p <0.05) 的IES得分显著改善.
- 在EMDR组中观察到,PTSD检查清单 (PCL-C) 和心理障碍积极和消极症状 (PANSS) 的负症状得分显著减少.
- 在所有其他评估尺度上都发现了积极的趋势,这表明了更广泛的好处.
结论:
- 这项研究证明了EMDR在减少英国社区心理健康环境中患有精神疾病的患者创伤事件的影响方面的有效性.
- 在EMDR治疗后观察到的心理健康症状的改善持续至少六个月.
- 研究结果支持将EMDR整合到精神疾病和创伤病史患者的社区心理健康服务中.
相关概念视频
Rational Emotive Behavior Therapy
54
Cognitive-behavioral therapies (CBTs) are grounded in the belief that our thoughts profoundly influence our emotions and actions. Advocates of CBT emphasize three core assumptions: first, that cognitions are identifiable and measurable; second, that they are central to psychological functioning; and third, that irrational or maladaptive beliefs can be replaced with rational and adaptive ones. This transformative approach to therapy has paved the way for specific models such as Albert...
54
Electroconvulsive Therapy
44
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
44
Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K


